Co-Diagnostics Operating Cash Flow 2011-2026 | CODX

Annual Operating Cash Flow Co-Diagnostics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-29.1 M	-29.2 M	-22.1 M	6.57 M	41.1 M	28.2 M	-5.53 M	-4.08 M	-3.21 M	-1.31 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
41.1 M	-29.2 M	-1.87 M

Quarterly Operating Cash Flow Co-Diagnostics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-8.75 M	-	-	-	-8.49 M	-	-	-	-5.5 M	-	10.6 M	9.46 M	7.81 M	-	36.2 M	24.7 M	12.3 M	-	8.21 M	-348 K	-1.34 M	-	-3.91 M	-2.7 M	-1.37 M	-	-3.12 M	-1.94 M	-969 K	-	-2.22 M	-668 K	-420 K	-	-756 K	-458 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
36.2 M	-8.75 M	2.88 M

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Myriad Genetics MYGN	1.8 M	$ 4.11	-18.29 %	$ 381 M	USA
National Research Corporation NRC	26.4 M	$ 17.86	-4.7 %	$ 400 M	USA
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Burning Rock Biotech Limited BNR	-478 M	$ 17.01	-0.09 %	$ 179 M	China
Agilent Technologies A	1.48 B	$ 117.69	0.14 %	$ 35.8 B	USA
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-48.7 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
CareDx, Inc CDNA	42 M	$ 20.94	1.16 %	$ 1.12 B	USA
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	-8 M	-	-	$ 9.42 M	Israel
HTG Molecular Diagnostics HTGM	-18.4 M	-	-20.0 %	$ 1.06 M	USA
Castle Biosciences CSTL	64.3 M	$ 24.75	0.61 %	$ 687 M	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	-5.66 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-524 M	-	0.12 %	$ 80.1 M	China
Medpace Holdings MEDP	713 M	-	-	$ 12.3 B	USA
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
Charles River Laboratories International CRL	738 M	$ 181.73	-1.97 %	$ 9.01 B	USA
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
NeoGenomics NEO	5.23 M	$ 8.89	0.34 %	$ 1.14 B	USA
Exact Sciences Corporation EXAS	491 M	-	-	$ 19.8 B	USA
Natera NTRA	-432 M	$ 215.09	4.02 %	$ 21.2 B	USA
Fulgent Genetics FLGT	21.1 M	$ 14.92	0.13 %	$ 451 M	USA
Personalis PSNL	-45.2 M	$ 6.07	9.17 %	$ 360 M	USA
Guardant Health GH	-185 M	$ 92.25	3.05 %	$ 11.6 B	USA
Heska Corporation HSKA	-21.8 M	-	-	$ 1.31 B	USA
Soleno Therapeutics SLNO	46.8 M	$ 52.94	0.04 %	$ 2.69 B	USA
ICON Public Limited Company ICLR	1.29 B	$ 124.13	2.32 %	$ 10.2 B	Irlanda
Illumina ILMN	837 M	$ 142.58	2.52 %	$ 22.7 B	USA
Senseonics Holdings SENS	-59.1 M	$ 5.36	7.2 %	$ 224 M	USA
Interpace Biosciences IDXG	5.83 M	-	-	$ 9.33 M	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Thermo Fisher Scientific TMO	7.82 B	$ 472.95	1.33 %	$ 178 B	USA
Biomerica BMRA	-3.84 M	$ 2.21	1.14 %	$ 5.08 M	USA
Trinity Biotech plc TRIB	-4.19 M	$ 0.6	0.42 %	$ 61.9 M	Irlanda
Lantheus Holdings LNTH	390 M	$ 86.15	0.38 %	$ 5.81 B	USA
Laboratory Corporation of America Holdings LH	1.64 B	$ 256.94	-0.08 %	$ 21.4 B	USA
Twist Bioscience Corporation TWST	-47.6 M	$ 59.53	4.99 %	$ 3.56 B	USA
Celcuity CELC	-153 M	-	-	$ 6.52 B	USA
Motus GI Holdings MOTS	-11.2 M	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	58.2 M	$ 9.18	-0.97 %	$ 1.99 B	USA
Waters Corporation WAT	653 M	$ 349.53	1.98 %	$ 20.8 B	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 189.13	-0.9 %	$ 21 B	USA